Fund managers team consultation and discuss about analysis Investment stock market by digital tablet.

FDA

Manufacturers in the USA are expected to compile and maintain documentation that demonstrates the analytical and clinical performance of their IVD devices. From analytical validation studies to regulatory submissions and post-market surveillance, navigating the clinical aspects of IVD development requires meticulous planning, execution and adherence to regulatory requirements.

Our team can support you in the following clinical areas.

  • Analytical and clinical performance evaluation: The FDA expects manufacturers to demonstrate both the analytical and clinical performance of their IVD devices. This involves conducting studies to assess the accuracy, precision, sensitivity, specificity and various other performance-related characteristics of the device.
  • Analytical validation studies: Manufacturers must conduct analytical validation studies to evaluate your device's performance under controlled laboratory conditions. These studies assess its ability to accurately and reliably measure analytes of interest.
  • Clinical validation studies: Clinical validation studies are conducted to evaluate the device's performance in real-world clinical settings. These studies compare the device's results to those of a reference method or gold standard and assess its diagnostic accuracy, sensitivity, specificity and various other clinical performance characteristics.
  • Post-market surveillance (PMS): Manufacturers must implement post-market surveillance programmes to monitor the performance of their IVD devices after they are placed on the market. This includes not only collecting and analysing data on device failures, adverse events and several other safety or performance issues but also taking appropriate corrective and preventive actions when required.
Focused group of diverse young designers working on a laptop together at a desk in their startup office

Trusted by top-tier teams worldwide

FAQs on MedTech clinical and post-market services

At Apotech, we aim to make our MedTech clinical and post-market services as simple to understand as possible, which is why we’re always on hand to answer any questions you might have. 

Here are some of the questions we get asked most often.

Featured case studies

Prosthesis manufacturer

Prosthesis manufacturer Introduction As part of their international development strategy, our client wanted to get MDSAP certified with a focus on Canada, Australia and Brazil. They were MDSAP certified within 7 months. Types MDSAP Audit Preparation, Quality Management System Review Scope of work Selecting the certification body (quotes, Q&A) Review of their quality management system…

Read More

Quarterly Internal Audits

Quarterly Internal Audits Introduction Quarterly Internal Audits Our client is a start-up medical device manufacturer of a body cooling device, for those with heat stroke. They are based in the UK and are undergoing ISO 13485 certification. Standards & Tools 21 CFR ISO 13485 MDSAP MDR Scope of work Key numbers Excited to work together…

Read More

Process and Test Method Validation Review and Improvement

Process and Test Method Validation Review and Improvement Introduction Cardiac Devices Our client is a leading manufacturer of Class III minimally invasive cardiac devices, based in Germany and selling to 85 countries worldwide. Apotech consultants Our consultants implemented a risk-based approach to improve quality and compliance, and implement practical solutions for the organisation. Standards &…

Read More

Ready to get started?